A novel genomic test could help doctors identify which men with high-risk prostate cancer need more aggressive treatment and which could safely avoid it, according to new research led by University College London that will be presented at the European Society for Medical Oncology Congress 2026 in Madrid.
organisation
University College London
Public research university in London